Psychedelics Investing Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
Psychedelics Investing Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
Psychedelics Investing Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
psychedelics investing Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
psychedelics investing Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
psychedelics investing Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global
psychedelics investing Optimi Health Enters Into International Collaborative Research and Supply Agreement With Promises Innovative Recovery Center
psychedelics investing Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors
psychedelics investing Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health
Turnium and Syntheia AI Commence Commercial Rollout of AI-Powered Communications Platform Across Partner Network
Surface Metals Inc. Engages Barwicki Investor Relations to Lead Strategic Investor Relations and Shareholder Communication Program
Spartan Metals Provides Encouraging Drill Assay Results for Tungstonia Tailings at its Eagle Project, Nevada
Homerun Resources Inc. 100% Owned Subsidiary Homerun Energy SRL Recognized as Key Innovator by European Commission's Innovation Radar
